SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-21-096567
Filing Date
2021-03-26
Accepted
2021-03-26 16:18:51
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM F-3 d154711df3.htm F-3 395730
2 EX-5.1 d154711dex51.htm EX-5.1 21116
3 EX-23.1 d154711dex231.htm EX-23.1 4090
4 GRAPHIC g154711dsp90.jpg GRAPHIC 3327
5 GRAPHIC g154711g02q20.jpg GRAPHIC 33289
6 GRAPHIC g154711g25e73.jpg GRAPHIC 3285
  Complete submission text file 0001193125-21-096567.txt   477340
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-254768 | Film No.: 21777654
SIC: 2834 Pharmaceutical Preparations